This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aratana Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Maryline Roe - Innovator in Veterinary Ophthalmology
Introduction
Maryline Roe is a distinguished inventor based in Leawood, Kansas. She has made significant contributions to the field of veterinary medicine, particularly in the area of ophthalmology. Her innovative work focuses on developing solutions for eye infections in companion animals.
Latest Patents
Maryline Roe holds a patent for an eye drop composition. This invention comprises 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one. The eye drop composition is designed for the diagnosis and treatment of herpetic eye infections in companion animals. This patent highlights her commitment to improving animal health through innovative solutions.
Career Highlights
Maryline Roe is currently employed at Aratana Therapeutics, Inc., a company dedicated to developing innovative therapeutics for pets. Her role at the company allows her to apply her expertise in veterinary medicine and contribute to the advancement of animal healthcare.
Collaborations
Maryline has collaborated with notable coworkers, including Ainola Billiet and Erwin Blomsma. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Maryline Roe's contributions to veterinary ophthalmology through her patented eye drop composition demonstrate her dedication to enhancing the health and well-being of companion animals. Her work at Aratana Therapeutics, Inc. and collaborations with her colleagues further emphasize her impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
